LifeStance Health Group (LFST) to Release Quarterly Earnings on Monday

LifeStance Health Group (NASDAQ:LFSTGet Rating) is scheduled to release its earnings data after the market closes on Monday, May 9th. Analysts expect LifeStance Health Group to post earnings of ($0.15) per share for the quarter. LifeStance Health Group has set its FY 2022 guidance at EPS and its Q1 2022 guidance at EPS.Investors that wish to register for the company’s conference call can do so using this link.

LifeStance Health Group (NASDAQ:LFSTGet Rating) last posted its quarterly earnings results on Thursday, March 10th. The company reported ($0.32) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.37) by $0.05. The business had revenue of $190.00 million for the quarter, compared to analyst estimates of $190.35 million. LifeStance Health Group had a negative return on equity of 20.93% and a negative net margin of 46.02%. On average, analysts expect LifeStance Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

NASDAQ LFST opened at $6.77 on Monday. LifeStance Health Group has a 12 month low of $6.42 and a 12 month high of $29.81. The firm has a 50-day moving average of $9.49. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.10.

A number of analysts have recently commented on the company. UBS Group cut LifeStance Health Group from a “buy” rating to a “neutral” rating and lowered their price target for the company from $19.00 to $10.00 in a research note on Thursday, March 17th. Zacks Investment Research cut shares of LifeStance Health Group from a “hold” rating to a “sell” rating in a research report on Thursday. Finally, The Goldman Sachs Group lowered their price objective on shares of LifeStance Health Group from $15.00 to $10.00 and set a “neutral” rating for the company in a research report on Monday, March 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $16.00.

In related news, CFO Jesse Michael Bruff sold 18,401 shares of the stock in a transaction dated Monday, March 14th. The stock was sold at an average price of $7.92, for a total transaction of $145,735.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kevin Michael Mullins sold 46,283 shares of the business’s stock in a transaction that occurred on Wednesday, April 20th. The shares were sold at an average price of $10.68, for a total value of $494,302.44. Following the completion of the sale, the insider now owns 5,669,472 shares in the company, valued at approximately $60,549,960.96. The disclosure for this sale can be found here.

A number of hedge funds have recently modified their holdings of LFST. Bank of America Corp DE bought a new stake in LifeStance Health Group during the 2nd quarter worth about $200,000. Invesco Ltd. acquired a new stake in shares of LifeStance Health Group in the third quarter valued at about $225,000. Morgan Stanley raised its holdings in LifeStance Health Group by 9,496.1% during the third quarter. Morgan Stanley now owns 80,607 shares of the company’s stock worth $1,168,000 after acquiring an additional 79,767 shares in the last quarter. Royal Bank of Canada boosted its position in LifeStance Health Group by 39,407.1% during the third quarter. Royal Bank of Canada now owns 5,531 shares of the company’s stock valued at $80,000 after purchasing an additional 5,517 shares during the last quarter. Finally, UBS Group AG grew its stake in LifeStance Health Group by 438.8% in the third quarter. UBS Group AG now owns 10,669 shares of the company’s stock valued at $155,000 after purchasing an additional 8,689 shares in the last quarter. Hedge funds and other institutional investors own 72.58% of the company’s stock.

About LifeStance Health Group (Get Rating)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Further Reading

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.